S-35225 decreases plasma PAI-1 activity both in vitro and in vivo

被引：0
|
作者：
Rupin, A. [1 ]
Gaertner, R. [1 ]
Mennecier, P. [1 ]
Benoist, A. [2 ]
De Nanteuil, G. [2 ]
Verbeuren, T. [1 ]
机构：
[1] Inst Rech Servier, Div Angiol, Suresnes, France
[2] Inst Rech Servier, Div Chem, Suresnes, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷
关键词：
PAI-1; inhibitor; activity; thrombolytic therapy;
D O I：
10.1111/j.1538-7836.2006.00171.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
171
引用
收藏
页码：166 / 166
页数：1
相关论文
共 41 条
  • [1] The Effect of PAI-1 Gene Variants and PAI-1 Plasma Levels on Development of Thrombophilia in Patients With Klinefelter Syndrome
    Erkal, Burcin
    Yigin, Aysel Kalayci
    Palanduz, Sukru
    Dasdemir, Selcuk
    Seven, Mehmet
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 12 (06) : 2152 - 2156
  • [2] Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: Relation to polymorphisms of PAI-1 and angiotensin converting enzyme (ACE) genes
    Margaglione, M
    Grandone, E
    Vecchione, G
    Cappucci, G
    Giuliani, N
    Colaizzo, D
    Celentano, E
    Panico, S
    DiMinno, G
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 2082 - 2087
  • [3] ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN A POPULATION OF NORTHERN SWEDEN
    RANBY, M
    SUNDELL, IB
    JOHNSON, O
    LEDIN, MC
    DAHLEN, G
    FIBRINOLYSIS, 1990, 4 : 54 - 55
  • [4] Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA
    Prisco, D
    Fedi, S
    Antonucci, E
    Capanni, M
    Chiarugi, L
    Chioccioli, M
    Falai, M
    Giglioli, C
    Abbate, R
    Gensini, GF
    THROMBOSIS RESEARCH, 2001, 104 (03) : 181 - 186
  • [5] Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity
    Hansen, JB
    Grimsgaard, S
    Nordoy, A
    Bonaa, KH
    THROMBOSIS RESEARCH, 2000, 98 (02) : 123 - 132
  • [6] BODY-COMPOSITION AND WEIGHT-REDUCTION IN RELATION TO ANTIGEN AND ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN OVERWEIGHT INDIVIDUALS
    HUISVELD, IA
    LEENEN, R
    VDKOOY, K
    HOSPERS, JEH
    SEIDELL, JC
    DEURENBERG, P
    KOPPESCHAAR, HPF
    MOSTERD, WL
    BOUMA, BN
    FIBRINOLYSIS, 1990, 4 : 84 - 85
  • [7] Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction
    Gray, RP
    Panahloo, A
    MohamedAli, V
    Patterson, DLH
    Yudkin, JS
    ATHEROSCLEROSIS, 1997, 130 (1-2) : 171 - 178
  • [8] Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum
    Yu, Bo
    Zhang, Guangping
    Jin, Lingling
    Zhang, Bo
    Yan, Dong
    Yang, Hong
    Ye, Zuguang
    Ma, Tonghui
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [9] Honokiol Restores Polymyxin Susceptibility to MCR-1-Positive Pathogens both In Vitro and In Vivo
    Guo, Yan
    Lv, Xiaohong
    Wang, Yanling
    Zhou, Yonglin
    Lu, Na
    Deng, Xuming
    Wang, Jianfeng
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2020, 86 (05)
  • [10] Role for RIP1 in mediating necroptosis in experimental intracerebral hemorrhage model both in vivo and in vitro
    Shen, Haitao
    Liu, Chenglin
    Zhang, Dongping
    Yao, Xiyang
    Zhang, Kai
    Li, Haiying
    Chen, Gang
    CELL DEATH & DISEASE, 2017, 8 : e2641 - e2641
12345